Artificial Intelligence driven Marketing Communications
ArborMetrix is a healthcare analytics and software firm specializing in hospital and specialty-based care.
ArborMetrix is a healthcare analytics and software firm
specializing in hospital- and specialty-based care. Our
comprehensive solutions turn noisy data into timely,
scientifically rigorous, and actionable information about
quality and cost.
real-time analytics and performance management platform
offers dynamically benchmarked, risk-adjusted
outcomes data from acute and specialty health care. Dramatically increase your understanding of quality and cost performance across anynetwork with scientifically rigorous data drawn from both clinical and administrative sources.
Brett is a senior executive with over 20 years of experience in selling and managing technology solutions within the manufacturing, CPG and healthcare industries. For the past seven years Brett established and led the Covisint Healthcare Division of Compuware (CPWR) as Vice President where he set the strategic direction and overall solution portfolio. Over that period, Covisint Healthcare became one of the largest and fastest growing SaaS providers in the nation focusing on health information exchange. Prior to Covisint, Mr. Furst held leadership roles at Infor, Dow Chemical and JBA International. He has a degree in Management Information Systems from Central Michigan University.
Dr. Birkmeyer, a graduate of Harvard Medical School, completed his General Surgery residency and a fellowship in health services research at Dartmouth. He then joined the Dartmouth faculty in 1996, later serving as Chief of General Surgery and as an editor for the Dartmouth Atlas of Healthcare. He moved to the University of Michigan in 2004, where he is the George D. Zuidema Professor of Surgery and Director of the Center for Healthcare Outcomes & Policy, a 120+ member research institute. Dr. Birkmeyer is an internationally recognized expert in performance measurement and strategies for reducing variation in hospital quality and costs. He has a long track record of research funding from the National Institutes of Health and the Agency for Healthcare Research & Quality.
Christian (Chris) has more than 15 years of experience in health services research, outcomes analysis, and software development. Prior to joining ArborMetrix, Chris was Executive Vice President at SCIOinspire responsible for software development, delivery and sales, and practice lead for analytics and actuarial services. Previously, he directed the informatics department at Health Dialog, managed the Data Center for the Department of Surgery at Dartmouth-Hitchcock Medical Center and consulted for The Leapfrog Group. He holds a B.S. in accounting from the University of Connecticut and a M.S. in epidemiology/biostatistics from Dartmouth.
Paul McCreadie joined Arboretum Ventures in 2006 as the firms first Associate and is now responsible for sourcing and leading new investment opportunities. He led Arboretums investment into ArborMetrix, Delphinus Medical Technologies and Wellfount Pharmacy and currently serves on the Board of Directors of each company.
Paul has also been a board observer at VasoNova (acquired by Teleflex) and NeoGuide. He is the former Chief Operating Officer for CerviLenz, a portfolio company based in Ohio, where he led the re-design of the companys first commercial product from concept to launch. Paul is responsible for the legal aspects of deal execution at Arboretum and works closely with outside counsel on legal matters.
Justin B. Dimick, MD, MPH is the Henry King Ransom Professor of Surgery, Chief of the Division of Minimally Invasive Surgery, and Associate Chair for Faculty Development at the University of Michigan. He is a national leader in outcomes research and health policy , with over 140 peer-reviewed publications, including papers in NEJM and JAMA. His research focuses on performance measurement, variation in hospital quality, and cost-quality relationships. With funding from the Agency for Healthcare Research and Quality (AHRQ) and the National Institutes of Health (NIH), his current research is evaluating Center for Medicare and Medicaid Services (CMS) policies for improving surgical care, including selective referral, pay-for-performance, and episode bundled payments. Dr.
Dr. Staiger is the John French Professor in Economics at Dartmouth and a Research Associate at the National Bureau of Economic Research in Cambridge, Massachusetts. He received his BA from Williams College in 1984 and his PhD in economics from MIT in 1990. Before joining the department in 1998, he was a faculty member at Stanford and Harvard. In partnership with Dr. Mark McClellan, he developed novel econometric methods for measuring the quality of care of hospitals, which have been highly influential in the field. His research has been funded by the National Institute of Health and published in leading economics and medical journals. Dr. Staiger was the recipient of the Arrow Award for the best paper in health economics in 2007, and the Eugene Garfield Economic Impact of Medical and Health Research Award in 2008.